Discussion
Inflammatory myofibroblastic tumors are rare benign structures with unknown aetiology. The most specific feature of IMTs, whose main cell type is myofibroblasts, is the ability to mimic malignancy. A histopathological examination of the IMTs revealed numerous lymphocytes, plasma cells and histiocytes settled between the spindle cells and fibrous tissues (5) . Although IMT was first described by Brunn, its pathological entities were identified in detail by Umiker and Iverson in 1954 (6) . Two theories have been emphasised to explain the aetiopathogenesis: the first is an abnormal host response to tissue damage, while the second is disorders in immunological responses (7, 8) . IMTs are known to be benign tumors with no capacity to metastasise. However, these tumors are known to infiltrate surrounding tissues due to their severe proliferative capacity and they are thus known to recur frequently, even after resection (9) . Although IMTs might be encountered in any organ or system in the body, they are most frequently localised in the lungs. However, they may also occur in the central nervous system, mediastinum, intra-abdominal organs and retroperitoneum. The most frequently involved organ in the abdomen is the liver, while primary gallbladder involvement is quite rare. Present knowledge about this entity is based on case reports in the literature (10) . The clinical picture in cases with IMT depends on the organ of involvement and site of the organ; abdominal pain, jaundice and ascites might be the presenting symptoms, according to the localisation in the liver involvement. Gallbladder involvement, on the other hand, may result in acute cholecystitis, biliary colic, obstructive jaundice and cholangitis may be seen in cases with extension to the common bile duct. Laboratory examinations of chronic diseases reveal anaemia, leukocytosis and an increase in C-reactive protein levels, due to the inflammatory features of the tumor; however, there is no specific tumor marker for IMTs (11) . Our case presented with signs of acute cholecystitis and moderate bile duct dilatation, due to the obstruction caused by the mass in the gallbladder. Laboratory values of this case are in accordance with other cases reported in the literature. There were no laboratory abnormalities besides leukocytosis and increased C-reactive protein levels. To diagnose IMT based on ancillary diagnostic methods, such as imaging studies, is considerably difficult. IMTs mimic malign tumors in imaging studies. Myofibroblastic proliferation is responsible for the confusion of IMTs with malign tumors. The denser the proliferation is, the greater the difficulty of reaching a differential diagnosis with malignancy (12) . Heterogeneous contrast enhancement is seen around the mass in abdominal tomography. Although imaging studies demonstrate a well-defined and homogeneous mass, areas of haemorrhage, necrosis and calcifications can also be seen. A target-like image, in addition to findings of hypo-density in T1 and hyper-density in T2 sequences, is seen in magnetic resonance imaging (13) . Today, 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) and positron emission tomography / computed tomography (PET/CT) has become a routine practice in the diagnosis and staging of cancers. Furthermore the use of PET in the clinic has been expanded with the detection of inflammatory cells showing FDG uptake, not only in malignant cells; also, PET has become routinely used to detect primary focus of infection which is undetectable the other radiological imaging modalities. The present-day confusion in PET and PET/CT is how to make the distinction between malignancy and inflammatory statements. This confusion could be solved with dual-time-point imaging with FDG-PET or FDG-PET/CT. The 18F-fluorodeoxyglucose uptake decreases with time in inflammatory and non-neoplastic lesions; however, glucose uptake in patients with malignant disease remains constant, which enables the identification of malignant cases. In our case, if we had acquired PET/CT in the preoperative period, we could have obtained details about the tumor, which would have changed our strategy (14, 15) . The inflammatory reaction in the mass without a capsule has been blamed for creating the image of infiltration. A definitive diagnosis can be achieved by needle biopsy or with histopathological examination of the resected specimen. In accordance with the literature, the information about the type of mass in half of the cases could be obtained with the help of preoperative clinical, laboratory and imaging data (16) . However, as discussed in detail above, inflammatory conditions may mimic malignancy or mask the malignancy. At this point, fine-needle biopsy, making the distinction between benign and malignant, may prevent the patient from undergoing unnecessary aggressive surgical treatments. Nilsson et al. (17) , with the aid of ultrasound-guided fine-needle biopsy, made a correct diagnosis in 15 cases preoperatively. In a series of other patients, Das et al. (18) observed malignancy in 40 of 55 patients with clinical and imaging. In our case, if fineneedle biopsy had been performed, the patient could have been protected from unnecessary surgical treatment. It is difficult to access small gallbladder masses with percutaneous needle biopsy (16); however, this problem can overcome with endoscopic ultrasonography-guided needle biopsy (19) . After biopsy of the gallbladder, abdominal pain (4.5%), bile peritonitis (1-6%) and needle tract seeding complications could be seen (19, 20) . Smooth muscle actin, CD68 and vimentin are positive on histopathological examination; however, S100, CD100 cytokeratin, CD35 and latent membrane proteins are negative. Atypia, hyperchromasia and abnormal mitotic figures are findings indicating a benign lesion; multi-centricity is rare. Fibrosarcomas are the first to come to mind as a differential diagnosis; other than fibrosarcomas, these lesions might be confused with follicular dendritic tumors and gastrointestinal autonomic nerve tumors (21) . Surgery is the only method of curative treatment for IMTs, as these tumors are resistant to radiotherapy and chemotherapy. There are reports indicating an increase in aggression of these tumors after such treatments. However, currently, there are some reports of successful results with the use of agents that show effects on target cells such as anti-inflammatory and anti-tumor necrosis factor-binding drugs. Peritoneal implant seeding and postoperative recurrence have been seen after surgery for IMTs. For inflammatory fibroblastic tumors with the primary therapeutic option of surgery, the mass should be resected with the surrounding tissue infiltrated with the tumor whenever possible via an R0 resection, leaving no tumor tissue behind. In addition, meticulous surgery should be performed in order to prevent peritoneal seeding (22) . In this case, an image of a mass was identified, filling the inside of the gallbladder almost completely, creating a target-sign effect and mimicking malignancy. We applied a surgical procedure with the initial diagnosis of gallbladder cancer, which was made according to the imaging studies and clinical findings of the patient. However, had we used an ultrasonographically-guided biopsy of the mass preoperatively, this could have prevented the patient from additional comorbidities while making the right diagnosis.
In conclusion, it should be kept in mind that inflammatory myofibroblastic tumors localised to the gallbladder might be confused with malignancy. Percutaneous histopathological sampling should be performed prior to surgery for proper diagnosis when a mass demonstrating inflammatory reactions and resembling a malignant tumor is encountered. In this way, the patient may be protected from a major abdominal surgery with high morbidity and mortality. 
